575 related articles for article (PubMed ID: 29110162)
1. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.
Quartarone G
Minerva Ginecol; 2013 Oct; 65(5):541-9. PubMed ID: 24096290
[TBL] [Abstract][Full Text] [Related]
3. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27671545
[TBL] [Abstract][Full Text] [Related]
4. Medical Treatment of Gastroesophageal Reflux Disease.
Kroch DA; Madanick RD
World J Surg; 2017 Jul; 41(7):1678-1684. PubMed ID: 28321555
[TBL] [Abstract][Full Text] [Related]
5. Medical treatments of GERD: the old and new.
Vela MF
Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
[TBL] [Abstract][Full Text] [Related]
6. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.
Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
Dis Esophagus; 2017 May; 30(5):1-9. PubMed ID: 28375448
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological management of GERD: where does it stand now?
Hershcovici T; Fass R
Trends Pharmacol Sci; 2011 Apr; 32(4):258-64. PubMed ID: 21429600
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
[TBL] [Abstract][Full Text] [Related]
9. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
Hillman L; Yadlapati R; Thuluvath AJ; Berendsen MA; Pandolfino JE
Dis Esophagus; 2017 Sep; 30(9):1-15. PubMed ID: 28859358
[TBL] [Abstract][Full Text] [Related]
10. Novel pharmaceutical approaches to reflux disease.
Dutta U; Armstrong D
Gastroenterol Clin North Am; 2013 Mar; 42(1):93-117. PubMed ID: 23452633
[TBL] [Abstract][Full Text] [Related]
11. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.
Ranaldo N; Losurdo G; Iannone A; Principi M; Barone M; De Carne M; Ierardi E; Di Leo A
Cell Death Dis; 2017 Sep; 8(9):e3040. PubMed ID: 28880273
[TBL] [Abstract][Full Text] [Related]
12. Optimal management of severe symptomatic gastroesophageal reflux disease.
Talley NJ; Zand Irani M
J Intern Med; 2021 Feb; 289(2):162-178. PubMed ID: 32691466
[TBL] [Abstract][Full Text] [Related]
13. An algorithm for diagnosis and treatment of refractory GERD.
Hershcovici T; Fass R
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):923-36. PubMed ID: 21126704
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic options for refractory gastroesophageal reflux disease.
Fass R
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():3-7. PubMed ID: 22486864
[TBL] [Abstract][Full Text] [Related]
15. New pharmacologic approaches in gastroesophageal reflux disease.
Armstrong D; Sifrim D
Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.
Manabe N; Haruma K; Ito M; Takahashi N; Takasugi H; Wada Y; Nakata H; Katoh T; Miyamoto M; Tanaka S
Dis Esophagus; 2012 Jul; 25(5):373-80. PubMed ID: 22050449
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial.
Foocharoen C; Chunlertrith K; Mairiang P; Mahakkanukrauh A; Suwannaroj S; Namvijit S; Wantha O; Nanagara R
Rheumatology (Oxford); 2017 Feb; 56(2):214-222. PubMed ID: 27179107
[TBL] [Abstract][Full Text] [Related]
18. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
Kahrilas PJ; Howden CW; Hughes N
Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
[TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease.
Chiu CT; Hsu CM; Wang CC; Chang JJ; Sung CM; Lin CJ; Chen LW; Su MY; Chen TH
Aliment Pharmacol Ther; 2013 Nov; 38(9):1054-64. PubMed ID: 24024757
[TBL] [Abstract][Full Text] [Related]
20. Treatment of reflux disease during pregnancy and lactation.
Dağlı Ü; Kalkan İH
Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S53-S56. PubMed ID: 29199169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
